Among them, PMP22 defects are found in more than one-third of CMT patients, and the genomic dosage of PMP22 is often the subject of prenatal diagnosis including the preimplantation genetic diagnosis [51]. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease.